A biotechnology company developing medicines that treat intractable diseases by silencing the genes that cause them.
Investment Insights
AI-generated insights about Arrowhead Pharmaceuticals, Inc. from various financial sources
Wednesday, August 13, 2025
Mentioned as a partner to Sarepta that accepted stock instead of cash, a move seen as a bullish sign of financial strength for Sarepta.
Tuesday, July 1, 2025
Mentioned positively as a partner with Sarepta for a new siRNA platform, which helps diversify Sarepta's pipeline into new disease areas.
Wednesday, August 13, 2025
Mentioned as a partner to Sarepta that accepted stock instead of cash, a move seen as a bullish sign of financial strength for Sarepta.
Tuesday, July 1, 2025
Mentioned positively as a partner with Sarepta for a new siRNA platform, which helps diversify Sarepta's pipeline into new disease areas.